Prediction of Clinical Trials Outcomes Based on Target Choice and Clinical Trial Design with Multi‐Modal Artificial Intelligence
Alex Aliper(Hong Kong Science and Technology Parks Corporation), Alex Zhavoronkov(Abu Dhabi University), Shan Chen(Jordan Valley Semiconductors (China)), Elena Tutubalina, Petrina Kamya, Feng Ren(Henan Medical University), Daniil Polykovskiy(Hong Kong Science and Technology Parks Corporation), Roman Kudrin(INSEAD)
Cited by 78
Related Papers
Deep biomarkers of human aging: Application of deep neural networks to biomarker development
|Aging|2016|377
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
|Chemical Science|2023|322
Validation of biomarkers of aging
|Nature Medicine|2024|299
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
|Nature Biotechnology|2024|265
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
|Journal of Chemical Information and Modeling|2023|196